Media

ConvaTec Announces 2015 Q4 / 2015 EOY Earnings Call

LUXEMBOURG (March 17, 2016) – ConvaTec today announced that it will hold an analyst and investor call to discuss 2015 fourth quarter and 2015 end-of-year results on Tuesday, March 22, 2016. Paul Moraviec, CEO and Nigel Clerkin, CFO will host the call at 9:00 AM EST live via telephone.

To participate in the conference call:• Within the U.S. and Canada, dial (844) 862-2257• Outside the U.S. and Canada, dial (760) 666-3086

Conference ID#: 73301605

Participants should dial in 10 minutes prior to the start of the call. The Company’s 2015 Annual Report will be available on the Company’s website prior to the call under the Investors tab at www.convatec.com.

About ConvaTec

ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has 9,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com

AQUACEL® Ag Dressing is not a drug • In all of our silver products, the anti-microbial activity occurs within the dressing. The correlation between in vitro testing and clinical effectiveness has not been evaluated.